Roivant Sciences Ltd.
ROIV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001635088
In the last 90 days, Roivant Sciences Ltd. insiders filed 0 open-market purchases and 8 sales; 500 institutions reported holding it in 13F filings for Q2 2026, worth $19.7B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
13F holders, Q2 2024
Institutional positions in Roivant Sciences Ltd. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 294
- +38 vs. Q1 2024
- Shares held
- 545.7M
- +14.6M (+2.7%) vs. Q1 2024
- Total value
- $5.77B
- +$169.4M (+3.0%) vs. Q1 2024
- New holders
- 64
- 102 more added
- Sold out
- 26
- 83 more reduced
3 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ROIV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 500 | $19.7B |
| Q1 2026 | 445 | $14.7B |
| Q4 2025 | 400 | $11.0B |
| Q3 2025 | 338 | $7.59B |
| Q2 2025 | 339 | $5.80B |
| Q1 2025 | 314 | $5.63B |
| Q4 2024 | 320 | $6.65B |
| Q3 2024 | 294 | $6.57B |
| Q2 2024 | 294 | $5.77B |
| Q1 2024 | 259 | $5.60B |
| Q4 2023 | 225 | $6.08B |
| Q3 2023 | 207 | $6.38B |
| Q2 2023 | 182 | $5.03B |
| Q1 2023 | 147 | $3.39B |
| Q4 2022 | 110 | $3.29B |
| Q3 2022 | 78 | $1.19B |
| Q2 2022 | 71 | $1.47B |
| Q1 2022 | 52 | $1.72B |
| Q4 2021 | 42 | $3.42B |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Roivant Sciences Ltd.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| American International Group, Inc. | 0 | $0 | 0.00% | −450,065−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −372,556−100.0% | Sold out |
| Texas Permanent School Fund | 0 | $0 | 0.00% | −295,505−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −149,489−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −91,192−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −85,952−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −84,422−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −70,618−100.0% | Sold out |
| Illinois Municipal Retirement Fund | 0 | $0 | 0.00% | −57,981−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −54,030−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −42,700−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −28,215−100.0% | Sold out |
| SC US (TTGP), Ltd. | 0 | $0 | 0.00% | −26,767−100.0% | Sold out |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −17,900−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,890−100.0% | Sold out |
| Dynamic Wealth Strategies, LLC | 0 | $0 | 0.00% | −2,400−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −121−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −99−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Oracle Alpha Inc. | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |